Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Regulatory News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.90
Bid: 2.80
Ask: 3.00
Change: 0.00 (0.00%)
Spread: 0.20 (7.143%)
Open: 2.90
High: 2.90
Low: 2.84
Prev. Close: 2.90
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

10 Jan 2018 15:19

RNS Number : 5221B
Allergy Therapeutics PLC
10 January 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Allergy Therapeutics PLC

LEI: 213800PQ7AHK7KGVOE23

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Placing of Shares

3. Details of person subject to the notification obligationiv

Name

Invesco Ltd.

City and country of registered office (if applicable)

1555 Peachtree Street NE, Suite 1800,

Atlanta, GA 30309 United States

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

09-01-2018

6. Date on which issuer notified (DD/MM/YYYY):

10-01-2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4.81%

0

4.81%

594,117,768

Position of previous notification (if

applicable)

5.62%

0

5.62%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

 

GB00B02LCQ05

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

28,618,373

4.81%

SUBTOTAL 8. A

28,618,373

4.81%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Invesco Asset

Management Limited.

4.81%

0

4.81%

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

Invesco (UK) Ltd.

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

 

Place of completion

Henley-on-Thames

Date of completion

10-01-2018

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEASFEFFPPEFF
Date   Source Headline
5th Jan 20217:00 amRNSInitiation of peanut allergy biomarker study
14th Dec 20203:58 pmRNSDirector/PDMR Shareholding
8th Dec 20202:42 pmRNSResult of Annual General Meeting
20th Nov 20201:51 pmRNSGrant of Awards under Long Term Incentive Plan
20th Nov 20207:00 amRNSDirector/PDMR Shareholding
10th Nov 20207:05 amRNSAnnual Report & Accounts and AGM Notification
26th Oct 20207:00 amRNSInitiation of Grass MATA MPL exploratory study
12th Oct 20207:00 amRNSHolding(s) in Company
9th Oct 20207:00 amRNSDirector Dealings and Issue of Equity
23rd Sep 20207:00 amRNSPreliminary Results
3rd Sep 20207:00 amRNSAGY secures VLP technology platform
20th Jul 20207:30 amEQSHardman & Co Research: Allergy Therapeutics (AGY): Record sales and a COVID-19 wildcard
15th Jul 202011:05 amRNSSecond Price Monitoring Extn
15th Jul 202011:00 amRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSTrading Update
9th Jul 20207:00 amRNSInvalidation of Birch MATA MPL phase III results
1st Jul 20205:15 pmRNSTotal Voting Rights
1st Jul 20205:14 pmRNSBLOCK LISTING SIX MONTHLY RETURN
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:36 pmRNSPrice Monitoring Extension
24th Jun 20207:00 amRNSTrading Update
18th May 20202:05 pmRNSSecond Price Monitoring Extn
18th May 20202:00 pmRNSPrice Monitoring Extension
23rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
23rd Apr 20204:36 pmRNSPrice Monitoring Extension
22nd Apr 202010:11 amRNSEAACI review of adjuvants and formulations
1st Apr 20201:09 pmRNSGrant and Vesting of Awards
9th Mar 20207:15 amEQSHardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth
4th Mar 20207:00 amRNSHalf-year Report
29th Jan 202012:00 pmRNSData for peanut allergy vaccine published in JACI
16th Jan 202012:25 pmRNSTrading Update & Notice of Results - Replacement
16th Jan 20208:00 amEQSHardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
16th Jan 20207:00 amRNSHalf Year Trading Update & Notice of Results
2nd Dec 20199:57 amRNSHoldings in Company
29th Nov 201910:34 amRNSHoldings in Company
26th Nov 20197:00 amRNSUpdate to Grass MATA MPL Ph III clinical programme
25th Nov 201912:13 pmRNSResult of Annual General Meeting
22nd Oct 20199:23 amRNSAnnual Report and Accounts
26th Sep 20197:30 amEQSHardman & Co Research: Allergy Therapeutics (AGY): Continuing to gain market share
25th Sep 20197:00 amRNSPreliminary Results
11th Jul 20197:00 amRNSTrading update
1st Jul 20197:21 amEQSHardman & Co Research: Allergy Therapeutics (AGY): Successful legal outcome removes uncertainty
1st Jul 20197:16 amEQSHardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value
27th Jun 20197:00 amRNSSuccessful Litigation Settlement
27th Jun 20197:00 amRNSTrading Statement
19th Jun 20197:00 amRNSBoard Change
11th Jun 20197:00 amRNSHoldings in Company
21st May 20197:15 amEQSHardman & Co Research: Allergy Therapeutics (AGY): House dust mite vaccine - clinical progress
20th May 20197:00 amRNSPositive top line phase I results for Acarovac MPL
14th May 20197:00 amRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.